EpiHeart (private company)
See something wrong or missing? Let us know
Offices:Helsinki
Industry:Health services
Business model:B2B
EpiHeart is a Finland-based medical device company dedicated to enable surgical administration of novel cellular and gene therapies. The first focus is Cardiac Micrograft Therapy, a novel autologous cellular therapy administered during CABG surgery to treat ischemic cardiac scars and heart failure.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 735.9k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to EpiHeart
Name | Criteria | |
---|---|---|
![]() |
3Z Pharmaceuticals
33%
|
|
![]() |
Abanza Tecnomed
33%
|
|
![]() |
ABLE Human Motion
33%
|
|
![]() |
Actimate
33%
|
|
![]() |
Adesante
33%
|
|
![]() |
ADmit Therapeutics
33%
|
|
![]() |
Amferia
33%
|
|
![]() |
Anatomic Studios
33%
|
|
![]() |
Aquilón CyL
33%
|
|
![]() |
Aristeia
33%
|
|